On Invalid Date, Adamis Pharmaceuticals (NASDAQ: ADMP) reported Q4 2022 earnings per share (EPS) of -$0.03, up 50% year over year. Total Adamis Pharmaceuticals earnings for the quarter were -$3.33 million. In the same quarter last year, Adamis Pharmaceuticals's earnings per share (EPS) was -$0.06.
As of Q2 2023, Adamis Pharmaceuticals's earnings has grown year over year. Adamis Pharmaceuticals's earnings in the past year totalled -$26.48 million.
What is ADMP's earnings date?
Adamis Pharmaceuticals's earnings date is Invalid Date. Add ADMP to your watchlist to be reminded of ADMP's next earnings announcement.
What was ADMP's revenue last quarter?
On Invalid Date, Adamis Pharmaceuticals (NASDAQ: ADMP) reported Q4 2022 revenue of $2.15 million up 285.49% year over year. In the same quarter last year, Adamis Pharmaceuticals's revenue was -$1.16 million.
What was ADMP's revenue growth in the past year?
As of Q2 2023, Adamis Pharmaceuticals's revenue has grown 115.34% year over year. This is 139.89 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 255.23%. Adamis Pharmaceuticals's revenue in the past year totalled $4.76 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.